New Delhi, April 05, 2016: Vijyoti, India’s leading corporate social enterprise with specialization in innovation management in the pharma and education sector has partnered with TEM International, a leading German medical technology company that is redefining bleeding control through its proprietary ROTEM® (Rotational Thromboelastometry) point-of-care diagnostic equipment to introduce cutting edge solutions for patient blood management in India.
ROTEM – The Optimal Haemostasis Analyser is the first choice solution for doctors globally in detecting, managing and monitoring haemostasis in cardiac surgery, liver transplant. obsetrics and trauma patients. The analyzer provides precise results within 5-10 minutes, whereas standard laboratory testing takes up to 40-60 minutes. The technology allows for targeted therapy to be provided at the point-of-care (POC).
Speaking on the occasion of India’s first National Symposium on Innovations in Bleeding Management, Dr. Klaus Goerlinger, Senior Consultant for Anaesthesiology, Intensive Care and Emergency Medicine, University Duisburg-Essen, Germany, said:. “Bleeding and blood transfusion have been shown to be independent risk factors for increased morbidity and mortality. Our collaboration with Vijyoti will help introduce ROTEM as an integral technology to patient blood management in India, one that will allow for point-of-care decisions for blood transfusion to be the last resort and not the first option to manage bleeding.”
ROTEM conducts four tests simultaneously – EXTEM, INTEM, FIBTEM and APTEM/HEPTEM. The easy-to-use portable device comes with a powerful intuitive software package and a sophisticated data handling system. The database stores all results and can be easily exported into MS Excel or other software for further processing.
Corporate Comm India (CCI Newswire)
New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…